Mercodia Glucagon ELISAs are the assays of choice for researchers globally, used in investigations studying pancreatic islets, diabetes therapies, obesity, NAFLD/NASH, nutrition, metabolomics, glucagon biosynthesis and secretion, among others.
Non-alcoholic fatty liver disease (NAFLD) is the most common liver condition in the Western world and an increasingly common indication for liver transplantation. It incorporates a spectrum of liver diseases characterized by abnormal accumulation of lipid (steatosis) arising in the absence of excess alcohol consumption. These diseases cover a continuum of stages ranging from steatosis, to nonalcoholic steatohepatitis (NASH) and cirrhosis, eventually resulting in liver failure. (1)
Mercodia offers a wide range of kits for the study of NASH/NAFLD disease:
Product |
Article no |
Kit format |
Mercodia Glucagon ELISA (CE-IVD) |
10-1271-01 |
1 x 96 wells |
Mercodia Glucagon ELISA - 10 µL rat/mouse |
10-1281-01 |
1 x 96 wells |
10-1278-01 |
1 x 96 wells | |
10-1113-01 |
1 x 96 wells | |
10-1132-01 |
1 x 96 wells | |
10-1247-01 |
1 x 96 wells | |
10-1249-01 |
1 x 96 wells | |
10-1250-01 |
1 x 96 wells | |
Bovine, Canine, Equine, Feline, Ovine, Porcine Insulin also available |
|
|
10-1251-01 |
1 x 96 wells | |
10-1145-01 |
1 x 96 wells | |
10-1199-01 |
1 x 96 wells | |
10-1143-01 |
1 x 96 wells |
DBA-ITALIA Srl
Via Umbria 10
20090 Segrate (Milano)
Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535